ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Suicide among patients with cancer: a retrospective study of medical treatment-related factors associated with suicide.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to identify the treatment-related factors associated with suicide in patients with cancer within the first two years following diagnosis.
methodsWe analyzed data from a hospital clinical database and national cause-of-death statistics to identify patients with cancer admitted to Kaohsiung Veterans General Hospital between January 2011 and December 2020 who died by suicide. Demographic characteristics and medical treatment information were collected. Patients with cancer who died by suicide (suicide group) were matched in a 1:4 ratio with those who did not die by suicide (non-suicide group) according to sex, age at diagnosis, year of diagnosis, cancer type, and cancer stage. Treatment-related factors were compared between the two groups using univariate and multivariate logistic regression analyses.
resultsAmong 32,479 patients with cancer, 78 died by suicide. Of these, 59 met the inclusion criteria and were included in the final analysis, alongside 236 matched patients who did not die by suicide. Univariate analyses revealed that the suicide group had higher rates of benzodiazepine and/or hypnotic use, antidepressant use, and psychiatric consultations. In multivariate analyses, benzodiazepine and/or hypnotic use and psychiatric consultation remained significantly associated with suicide, whereas antidepressant use did not.
conclusionPatients with cancer who died by suicide were more likely to have received benzodiazepines and/or hypnotics and psychiatric consultations within two years of diagnosis. These associations likely reflect greater underlying psychiatric distress and unmet mental health needs rather than treatment-related harm.
Indexed as
Identifiers
42295441What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.